US 11634424
Diazaindole derivative and use thereof as CHK1 inhibitor
granted A61PA61P35/00
Quick answer
US patent 11634424 (Diazaindole derivative and use thereof as CHK1 inhibitor) held by Medshine Discovery Inc. expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P35/00